Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis

(2011) Terrence C. H. Tan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival

(2011) Tobias J. Weismüller et al.   HEPATOLOGY

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2011) Joel E. Lavine   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients

(2011) Pinelopi Manousou et al.   LIVER INTERNATIONAL

Hepatic iron loading in mice increases cholesterol biosynthesis

(2010) Ross M. Graham et al.   HEPATOLOGY

Serum ferritin concentration predicts mortality in patients awaiting liver transplantation

(2010) Nicole M. Walker et al.   HEPATOLOGY

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

(2010) Brent A. Neuschwander-Tetri et al.   HEPATOLOGY

Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease

(2010) James E. Nelson et al.   HEPATOLOGY

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease

(2010) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

(2010) Anna Ludovica Fracanzani et al.   JOURNAL OF HEPATOLOGY

Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease

(2010) Paul Calès et al.   LIVER INTERNATIONAL

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease

(2010) L. Valenti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C

(2009) Francesca Ferrara et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation

(2009) Masato Yoneda et al.   DIGESTIVE DISEASES AND SCIENCES

HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Luca Valenti et al.   GASTROENTEROLOGY

Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis

(2009) Koji Fujita et al.   HEPATOLOGY

Hyperferritinemia is a risk factor for steatosis in chronic liver disease

(2009) Anna Licata et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Ferritins: A family of molecules for iron storage, antioxidation and more

(2008) Paolo Arosio et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease

(2008) Takehiro Nakagawa et al.   CLINICA CHIMICA ACTA

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells

(2008) Richard G. Ruddell et al.   HEPATOLOGY

Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload

(2008) Robert Brudevold et al.   PLoS One